April 18, 2013
Düsseldorf, April 18, 2013 – A dividend of EUR 0.65 per share was approved at the Annual General Meeting of Gerresheimer AG held today in Düsseldorf. The...
More April 16, 2013
Production of components for a further Sanofi insulin pen Düsseldorf, April 16, 2013. Gerresheimer has commenced production of components for another insulin...
More April 10, 2013
First-quarter revenues up 10.4% to EUR 296.7m Adjusted EBITDA margin reaches 15.5% Net income grows by 41.7% to EUR 10.2m Adjusted earnings per share...
More February 14, 2013
Updated version March 08, 2013 Updated: 6th paragraph, last sentence New: "unlike in previous years" and "not payable tax free" Revenues rise by 11.4% (9.8%...
More December 18, 2012
Düsseldorf/New Delhi, December 18, 2012 – Gerresheimer AG, one of the world’s leading partners of the pharma and healthcare industry, today announced that it...
More 